BiotechTube
Genomic Testing Cooperative

Genomic Testing Cooperative

Irvine, United States· Est.
genomictestingcooperative.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

Founded in 2018, Genomic Testing Cooperative is a commercial-stage diagnostics company focused on delivering comprehensive genomic profiling for oncology. Its core differentiators are a cooperative business model, a fully integrated NGS platform analyzing both DNA and RNA, and a strong emphasis on rapid turnaround times, averaging under 7 days for DNA tests. GTC's offerings include tissue-based panels and its Liquid Trace® liquid biopsy test, supported by proprietary AI-driven informatics for data interpretation.

Oncology

Technology Platform

Integrated NGS platform for DNA and RNA sequencing from tissue and liquid biopsy (cfDNA/cfRNA), supported by proprietary AI-driven bioinformatics (Interprestation™) for comprehensive genomic profiling and interpretation.

Funding History

2
Total raised:$30M
Series B$20M
Series A$10M

Opportunities

The growing adoption of comprehensive genomic profiling as standard-of-care in oncology and the rapid expansion of the liquid biopsy market present significant growth opportunities.
GTC's cooperative model offers a unique value proposition to healthcare providers, potentially driving customer loyalty and shared data asset creation.

Risk Factors

The company faces intense competition from larger, well-established diagnostic labs with greater sales reach and payer relationships.
Navigating complex and evolving reimbursement landscapes for NGS and liquid biopsy tests, and successfully scaling its partnership-dependent cooperative model, are key execution risks.

Competitive Landscape

GTC competes in the comprehensive genomic profiling market against major players like Foundation Medicine (Roche), Guardant Health, Caris Life Sciences, and Tempus. Its differentiation lies in its integrated DNA/RNA approach, fast turnaround times, AI-driven informatics, and unique cooperative business model, which contrasts with the centralized lab model of its larger competitors.

More companies in Diagnostics & Precision Medicine →More companies in United States →